首页> 外国专利> Highly active lysophosphatidic acid and screening method using the same

Highly active lysophosphatidic acid and screening method using the same

机译:高活性溶血磷脂酸及其使用方法

摘要

To provide a highly active LPA and a method of screening therewith. There is provided a method of screening a preventive and/or therapeutic substance for diseases in which LPA takes part, characterized in that a compound represented by any of formula (I), (II) and (III): [wherein the meaning of characters are described in the description] is used. The compounds obtained by the screening method or the screening kit of the present invention, their salts, their solvates and prodrugs thereof would modulate the binding of highly active LPA with LPA receptor in human and other mammals, so that they can be used as a preventive and/or therapeutic agent for diseases in which LPA takes part, for example, urinary diseases, central nervous diseases, inflammatory diseases, circulatory diseases, cancer, diabetes, immune system disorders and alimentary diseases.
机译:提供一种高活性的LPA及其筛选方法。本发明提供一种筛选LPA参与的疾病的预防和/或治疗物质的方法,其特征在于由式(I),(II)和(III)中的任何一个表示的化合物:在描述中使用]。通过本发明的筛选方法或筛选试剂盒获得的化合物,其盐,其溶剂化物和前药将调节高活性LPA与人和其他哺乳动物中LPA受体的结合,因此它们可用作预防剂和/或LPA参与的疾病的治疗剂,例如泌尿疾病,中枢神经疾病,炎性疾病,循环系统疾病,癌症,糖尿病,免疫系统疾病和消化系统疾病。

著录项

  • 公开/公告号JP4779650B2

    专利类型

  • 公开/公告日2011-09-28

    原文格式PDF

  • 申请/专利权人 小野薬品工業株式会社;

    申请/专利号JP20050516609

  • 发明设计人 林 昭夫;中出 眞嗣;鈴木 秀博;

    申请日2004-12-22

  • 分类号C07F9/10;G01N33/50;G01N33/15;G01N33/53;A61K45;A61P43;A61P13;A61P25;A61P29;A61P9;A61P35;A61P3/10;A61P37/02;A61P1;A61P7/10;A61P13/02;C12Q1/02;C07K16/44;C12P9;C07F9/6571;C07F9/655;

  • 国家 JP

  • 入库时间 2022-08-21 18:19:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号